(Q45864946)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Treatment related factors and inhibitor development in children with severe haemophilia A (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

David Keeling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

P S Maclean

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M Richards

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M Williams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

P Collins

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

R Liesner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

T Yee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A M Will

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

E A Chalmers

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Paediatric Working Party of UKHCDO

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

11 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

282-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

The economic impact of factor VIII inhibitors in patients with haemophilia

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

The epidemiology of factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development in hemophilia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

Prophylactic treatment effects on inhibitor risk: experience in one centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2010.02422.X

10.1111/J.1365-2516.2010.02422.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21070501%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference